0000950170-24-088663.txt : 20240731 0000950170-24-088663.hdr.sgml : 20240731 20240731164813 ACCESSION NUMBER: 0000950170-24-088663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240729 FILED AS OF DATE: 20240731 DATE AS OF CHANGE: 20240731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahmood Nadir CENTRAL INDEX KEY: 0001816598 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 241162692 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-07-29 0001787400 Nkarta, Inc. NKTX 0001816598 Mahmood Nadir C/O NKARTA, INC. 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 false true false false President false Stock Option (right to buy) 6.69 2024-07-29 4 A false 550000 0 A 2034-07-28 Common Stock 550000 550000 D The option is scheduled to vest and become exercisable as to 25% of the shares subject to the grant on July 29, 2025. The remaining portion of the option is scheduled to vest and become exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 29, 2025. /s/ Alicia Hager, as Attorney-in-Fact 2024-07-31